About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

New Technological Pathway for Gait Rehabilitation | Clinical Trials | Clareo Health

Back to clinical trial search

Not Yet RecruitingNANCT06859229

New Technological Pathway for Gait Rehabilitation

\*\*Brief Summary\*\* The study aims to explore how the integration of visual and motor systems can be trained and enhanced to improve gait rehabilitation in patients with various neurological and ca...

Lead sponsor: IRCCS Centro Neurolesi Bonino Pulejo•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Rocco Salvatore Calabrò, MD, PhD

CONTACT

+3909060128179 [email protected]

Mirjam Bonanno, PT, MSc

CONTACT

+3909060128179 [email protected]

Sponsors

Lead Sponsor

IRCCS Centro Neurolesi Bonino Pulejo

Age

18 - 60 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patients with a Montreal Cognitive Assessment (MoCA) score, corrected for age and education, equal to or greater than 20.
•Subjects capable of walking independently (Functional Ambulation Categories - FAC \> 2).

Exclusion Criteria

•Cognitive impairments that compromise the understanding and/or execution of the proposed exercises.
•Associated comorbidities that prevent maintaining an upright position or walking (e.g., hypotension).
•Refusal or inability to provide informed consent.
•Patients with contraindications to the use of the technological equipment required for the dynamic movement pathway.

Related studies

Study on Construction of Whole Lifecycle Cohort, Big Data Management and Clinical Prognosis of Cardio-Renal-Metabolic (CKM) Syndrome

NCT07547098 · Cardiovascular Diseases (CVD), Chronic Kidney Disease, and more

HARP Mindfulness Study

NCT05841784 · Cardiovascular Diseases

RECRUITINGPhase 3

A Phase 3 Study of NTLA-2001 in ATTRv-PN

NCT06672237 · Neuromuscular Disease, Neuromuscular Diseases (NMD), and more

Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder

NCT05516277 · Posttraumatic Stress Disorder, Insomnia, and more

RECRUITINGPhase 2/3

PRECISION-BP: Precision Chronopharamacotherapy Targeting NP-RAAS-BP Rhythm Axis

NCT04971720 · Obesity, Cardiovascular Diseases, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 5, 2025Terms

Trial snapshot

StatusNOT_YET_RECRUITING

PhaseNA

Enrollment60

Start dateMar 2025

Last updatedMar 5, 2025

Condition

Neurological Diseases or Conditions Cardiovascular Diseases Neuromuscular Disease

Locations shown

IRCCS Centro Neurolesi Bonino-Pulejo

Messina, Maine

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 5, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions